+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Thrombosis Drugs Market 2019-2023 - Product Image

Global Thrombosis Drugs Market 2019-2023

  • ID: 4718459
  • Report
  • November 2018
  • Region: Global
  • 109 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • DAIICHI SANKYO
  • Johnson & Johnson
  • Sanofi
  • MORE
About this market

Sedentary lifestyle is resulting in an increase in the number of thrombosis cases. The increase in sedentary lifestyle is leading to the rise in the prevalence of obesity across the world, thus increasing the risk of thrombosis. The analysts have predicted that the thrombosis drugs market will register a CAGR of more than 9% by 2023.

Market Overview

Growing awareness of cardiac care

The increasing awareness of cardiac care is leading to the early diagnosis of various cardiac diseases. Various awareness camps have been organized by the governments and non-government organizations across the world to increase the awareness of heart health among the population.

Strong side-effects of anticoagulants

Anticoagulants or blood thinners are medications that are developed to dissolve blood clots in the body. Blood thinners have high efficacy. However, the side effects associated with the use of these drugs to treat thrombosis are high.

For the detailed list of factors that will drive and challenge the growth of the thrombosis drugs market during the 2019-2023, view the full report.

Competitive Landscape

The market appears to be concentrated and with the presence of several companies including Johnson & Johnson, and Sanofi, the competitive environment is quite intense. Factors such as the increase in sedentary lifestyle and the increasing awareness of cardiac care, will provide considerable growth opportunities to thrombosis drugs manufactures. Boehringer Ingelheim, Bristol-Myers Squibb, DAIICHI SANKYO, Johnson & Johnson, and Sanofi are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • DAIICHI SANKYO
  • Johnson & Johnson
  • Sanofi
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY INDICATION
  • Market segmentation by indication
  • Comparison by indication
  • Pulmonary embolism - Market size and forecast 2018-2023
  • DVT - Market size and forecast 2018-2023
  • Market opportunity by indication
PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • DAIICHI SANKYO
  • Johnson & Johnson
  • Sanofi
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
PART 15: About the Author

List of Exhibits
Exhibit 01: Years in consideration
Exhibit 02: Global hematology drugs market
Exhibit 03: Segments of global hematology drugs market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Global thrombosis drugs market pipeline: Overview
Exhibit 19: Indication - Market share 2018-2023 (%)
Exhibit 20: Comparison by indication
Exhibit 21: Pulmonary embolism - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Pulmonary embolism - Year-over-year growth 2019-2023 (%)
Exhibit 23: DVT - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: DVT - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by indication
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 31: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 33: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Decision framework
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Boehringer Ingelheim - Vendor overview
Exhibit 45: Boehringer Ingelheim - Business segments
Exhibit 46: Boehringer Ingelheim - Organizational developments
Exhibit 47: Boehringer Ingelheim - Geographic focus
Exhibit 48: Boehringer Ingelheim - Segment focus
Exhibit 49: Boehringer Ingelheim - Key offerings
Exhibit 50: Boehringer Ingelheim - Key customers
Exhibit 51: Bristol-Myers Squibb - Vendor overview
Exhibit 52: Bristol-Myers Squibb - Business segments
Exhibit 53: Bristol-Myers Squibb - Organizational developments
Exhibit 54: Bristol-Myers Squibb - Geographic focus
Exhibit 55: Bristol-Myers Squibb - Key offerings
Exhibit 56: Bristol-Myers Squibb - Key customers
Exhibit 57: DAIICHI SANKYO - Vendor overview
Exhibit 58: DAIICHI SANKYO - Business segments
Exhibit 59: DAIICHI SANKYO - Organizational developments
Exhibit 60: DAIICHI SANKYO - Geographic focus
Exhibit 61: DAIICHI SANKYO - Key offerings
Exhibit 62: DAIICHI SANKYO - Key customers
Exhibit 63: Johnson & Johnson - Vendor overview
Exhibit 64: Johnson & Johnson - Business segments
Exhibit 65: Johnson & Johnson - Organizational developments
Exhibit 66: Johnson & Johnson - Geographic focus
Exhibit 67: Johnson & Johnson - Segment focus
Exhibit 68: Johnson & Johnson - Key offerings
Exhibit 69: Johnson & Johnson - Key customers
Exhibit 70: Sanofi - Vendor overview
Exhibit 71: Sanofi - Business segments
Exhibit 72: Sanofi - Organizational developments
Exhibit 73: Sanofi - Geographic focus
Exhibit 74: Sanofi - Segment focus
Exhibit 75: Sanofi - Key offerings
Exhibit 76: Sanofi - Key customers
Exhibit 77: Validation techniques employed for market sizing
Exhibit 78: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • DAIICHI SANKYO
  • Johnson & Johnson
  • Sanofi
  • MORE
Global Thrombosis Drugs Market 2019-2023

The author of the report recognizes the following companies as the key players in the global thrombosis drugs market: Boehringer Ingelheim, Bristol-Myers Squibb, DAIICHI SANKYO, Johnson & Johnson, and Sanofi.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increase in sedentary lifestyle.”

According to the report, one of the major drivers for this market is the increasing awareness of cardiac care.

Further, the report states that one of the major factors hindering the growth of this market is the strong side-effects of anticoagulants.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • DAIICHI SANKYO
  • Johnson & Johnson
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll